ArticleThe Journal of thoracic and cardiovascular surgery2020
Time-varying analysis of readmission and mortality during the first year after pneumonectomy.
Article in The Journal of thoracic and cardiovascular surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06534489 (Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment), which is not on this map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
Who cites it
5 citing papers in PubMed.
- Mortality and predictive models for 90-/180- day postoperative death for NSCLC patients aged ≥70 years.Journal of thoracic disease · 2026Article
- Effect of laterality on the postoperative survival of non-small cell lung cancer patients undergoing pneumonectomy.Translational lung cancer research · 2024Article
- Determining the optimal time to report mortality after lobectomy for lung cancer: An analysis of the time-varying risk of death.JTCVS open · 2023Article
- Surgical training in extended sleeve lobectomy with fresh-frozen human cadavers: a case report.General thoracic and cardiovascular surgery cases · 2023Article
- Cover always the bronchial stump! A flap could prevent catastrophic complications even in complete broncho-pleural fistula.Indian journal of thoracic and cardiovascular surgery · 2022Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
12 authors.
Funding
Abstract
objectivesMortality rates of 5% to 10% after pneumonectomy have remained constant during the last decade. To understand the patterns of outcomes after pneumonectomy, we investigated the time-varying risks of readmission and death during the first postoperative year and examined the contributions of specific causes to these patterns over time.
methodsWe retrospectively reviewed all pneumonectomies for lung cancer at our institution from 2000 to 2018. The time-varying instantaneous risk of all-cause readmission and mortality up to 1 year after pneumonectomy was estimated using parametric analyses and was repeated for each primary cause of readmission (oncologic, infectious, pulmonary, cardiac, or other) and death (oncologic or nononcologic).
resultsIn our cohort of 355 patients who underwent pneumonectomy, risk of readmission was highest immediately after discharge and was halved by 14 days. This risk reached a nadir and remained constant from 4 to 8 months, after which it gradually increased. Pulmonary causes accounted for most readmissions within 90 days, after which oncologic causes predominated. Likewise, the overall risk of death was highest immediately after surgery, was halved by 7 days, reached a nadir at 90 days, and then increased throughout the remainder of the first year. All deaths during the first 90 days after surgery were due to nononcologic causes.
conclusionsNononcologic causes of readmission and death predominate in the first 90 days after pneumonectomy, after which oncologic causes prevail. We also identify specific causes that pose the highest risk of readmission immediately after discharge. Efforts are warranted to define the effects of specific causes of readmission on overall mortality after pneumonectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.